Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of a FXIIa-inhibitor in the treatment of renal fibrosis and/or chronic kidney disease

Use of a FXIIa-inhibitor in the treatment of renal fibrosis and/or chronic kidney disease

US Patent 11505619 · Granted Nov 22, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Nucleic acids encoding antibodies against human granulocyte-colony stimulating f2024
Therapy using a factor XII inhibitor in a neurotraumatic disorder2024
CD131 binding proteins and uses thereof2023
Human serum albumin variants and uses thereof2022
Methods of administering inhibitory anti-factor XII/XIIa monoclonal antibodies2022
Methods of administering inhibitory anti-factor XII/XIIa monoclonal antibodies2022
Method of treating atherosclerosis2021
Treatment and prevention of remote ischemia-reperfusion injury2021
Mutated truncated von Willebrand Factor2020
Mutated von Willebrand factor2020
Methods of administering inhibitory anti-factor XII/XIIA monoclonal antibodies2019
Methods of administering inhibitory anti-factor XII/XIIA monoclonal antibodies2019